CD4 and Splenomegaly: Rottlerin effectively limited the splenomegaly induced by IMQ and altered the percentages of CD3+CD4+ T cells and CD3+CD8+ T cells in the spleen and skin, while ameliorating of imiquimod-induced psoriasiform inflammation.